NCT04805658进行中（未招募）不适用
Natural History Study of Retinitis Pigmentosa Type 11
Oslo University Hospital1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2021年2月1日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 30
- 试验地点
- 1
- 主要终点
- Progression of disease
研究概览
简要总结
Observational study of patients with retinitis pigmentosa type 11
详细描述
Natural history study with clinical examination every 6 months.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Clinical diagnosis of retinitis pigmentosa caused by a disease-causing mutation involving the PRPF31 gene
- •Or disease-causing mutation involving the PRPF31 gene without the clinical diagnosis of retinitis pigmentosa
排除标准
- •Under 18 years
- •Other types of retinitis pigmentosa
结局指标
主要结局
Progression of disease
时间窗: 24 mounths
Retinal function measured by functional and structural testing
次要结局
未报告次要终点
研究者
Josephine Prener Holtan
Senior Consultant, MD PhD
Oslo University Hospital
研究点 (1)
Loading locations...
相似试验
Unknown
不适用
Retrospective Natural History Study of Retinitis PigmentosaRetinitis Pigmentosa (RP)NCT03975543SparingVision113
进行中（未招募）
不适用
Prospective Natural History Study of Retinitis PigmentosaRetinitis PigmentosaNCT04285398SparingVision82
已完成
不适用
Retinitis Pigmentosa Clinical Measures and Repeatability Testing of Potential Outcome MeasuresRetinitis PigmentosaNCT03845218National Eye Institute (NEI)49
进行中（未招募）
不适用
A Prospective, Observational Study in Adults With Retinitis Pigmentosa (RP)Retinitis PigmentosaNCT06517940Sumitomo Pharma America, Inc.12
已完成
3 期
Management of Retinitis Pigmentosa Via Combination of Wharton's Jelly-derived Mesenchymal Stem Cells and MagnovisionRetinitis PigmentosaNCT05800301Ankara Universitesi Teknokent80